🔎 Trials Near Me

홈 › 폐암 › 켄터키

켄터키의 폐암 임상 시험

폐암 관련 연구 25개가 켄터키 내 여러 지역에서 참여자를 모집하고 있습니다.

켄터키의 도시

공식 연구 텍스트(영어)

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  • Baptist Health Lexington, Lexington
  • University of Kentucky Chandler Medical Center, Lexington
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07063745

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

  • University of Kentucky Chandler Medical Center ( Site 0019), Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06780098

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Baptist Health Corbin, Corbin
  • Baptist Health Hardin, Elizabethtown
  • Baptist Health Lexington, Lexington
  • 외 3개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • University of Kentucky/Markey Cancer Center, Lexington
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
피험자 모집 중3상
70세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06096844

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0061), Edgewood
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06312137

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Norton Cancer Institute, Louisville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
  • Commonwealth Cancer Center-Corbin, Corbin
  • Saint Elizabeth Healthcare Edgewood, Edgewood
  • 외 5개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of Kentucky Chandler Medical Center, Lexington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

  • James Graham Brown Cancer Center (Melanoma/NSCLC), Louisville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06060613

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  • Baptist Health Hardin, Elizabethtown
  • Baptist Health Lexington, Lexington
  • University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06712316

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • University of Kentucky/Markey Cancer Center, Lexington
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06287775

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

  • University of Kentucky ( Site 0019), Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT06731907

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Baptist Health Hardin Cancer Center, Elizabethtown
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06712355

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • University of Kentucky/Markey Cancer Center, Lexington
피험자 모집 중2상
18 Minutes · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Markey Cancer Center at Lexington Clinic, Lexington
  • University of Kentucky/Markey Cancer Center, Lexington
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06616584

A Study of ZW251 in Participants With Advanced Solid Tumors

  • Norton Cancer Institute, Louisville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07164313

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Louisville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT05433142

EXoPERT EMERALD Clinical Study

  • Lexington VA Healthcare System, Lexington
  • KCTL, Louisville
피험자 모집 중관찰 연구건강한 지원자 환영
45세 이상 · 모든 성별 · 2026. 7. 1. 업데이트됨 · NCT07186296

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • University of Louisville, Louisville
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 6. 26. 업데이트됨 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

  • University of Louisville, Louisville
피험자 모집 중1/2상
18세 ~ 70세 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • University of Kentucky/Markey Cancer Center, Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

  • University of Kentucky, Lexington
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 5. 8. 업데이트됨 · NCT06047301

Precision Lung Cancer Survivorship Care Intervention

  • Markey Cancer Center, Lexington
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 2. 23. 업데이트됨 · NCT05857995

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • University of Kentucky Markey Cancer Center, Lexington
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

  • Lexington VA Health Care System, Lexington
  • Robley Rex VA Medical Center, Louisville
피험자 모집 중관찰 연구
29세 ~ 85세 · 모든 성별 · 2024. 11. 13. 업데이트됨 · NCT06426628

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.